{"id":610389,"date":"2026-08-26T19:57:38","date_gmt":"2026-08-26T19:57:38","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/610389\/creative-biolabs-expands-specialized-exosome-isolation-services-for-extracellular-vesicle-research.html"},"modified":"2026-08-26T19:57:38","modified_gmt":"2026-08-26T19:57:38","slug":"creative-biolabs-expands-specialized-exosome-isolation-services-for-extracellular-vesicle-research","status":"publish","type":"post","link":"https:\/\/www.olympiajournal.com\/news\/story\/610389\/creative-biolabs-expands-specialized-exosome-isolation-services-for-extracellular-vesicle-research.html","title":{"rendered":"Creative Biolabs Expands Specialized Exosome Isolation Services for Extracellular Vesicle Research"},"content":{"rendered":"
Creative Biolabs has expanded its custom exosome isolation platform to support extracellular vesicle research across complex biological matrices.<\/div>\n

New York, USA – August 26, 2026 –<\/strong> Designed exclusively for academic and preclinical research, the expanded service portfolio addresses fundamental technical bottlenecks in extracting high-purity extracellular vesicles (EVs) from complex biological matrices. This structural enhancement provides researchers with scalable, reproducible vesicle populations necessary for advanced multi-omics profiling, biomarker discovery, and cargo delivery investigations.<\/p>\n

\"\"<\/p>\n

Overcoming Heterogeneity in Biological Matrices<\/strong><\/p>\n

The inherent heterogeneity of biological samples frequently compromises the yield and structural integrity of isolated extracellular vesicles. Co-isolated contaminants, such as lipoproteins and protein aggregates, can severely skew downstream transcriptomic and proteomic data.<\/p>\n

To resolve these biochemical challenges, Creative Biolabs has optimized proprietary protocols for comprehensive body fluid exosome isolation<\/a>. By utilizing a combination of optimized size-exclusion chromatography (SEC), density gradient ultracentrifugation, and immunoaffinity capture, this methodology is designed to preserve vesicle integrity while supporting downstream functional analysis.<\/p>\n

Tailored Protocols for Circulating and Excreted Fluids<\/strong><\/p>\n

Blood-based matrices are widely used in liquid biopsy research. Recognizing the distinct rheological properties of these samples, the company has introduced highly refined protocols for the extraction of exosomes from serum and plasma<\/a>. The workflows are designed to reduce abundant protein contaminants while recovering intact EV populations suitable for downstream RNA and protein analysis.<\/p>\n

Concurrently, to support non-invasive diagnostic research, Creative Biolabs has standardized its urine exosome profiling capabilities. By carefully adjusting for physiological variations in urine osmolarity and mitigating Tamm-Horsfall protein entanglement, the platform supports the isolation of vesicle populations for nephrology- and urology-focused biomarker studies.<\/p>\n

Beyond mammalian biofluids, the company’s capabilities also extend into the emerging field of plant-derived nanovesicles, offering specialized extraction from botanical sources, such as tomato-derived exosome-like nanoparticles<\/a>, to support research into plant-derived nanovesicles and their potential biological interactions.<\/p>\n

Expert Perspectives and Stringent Quality Control<\/strong><\/p>\n

“Achieving consistent exosome purity from protein-rich or highly variable biofluids is a critical threshold for reproducible omics analysis,” stated the Senior Director of Extracellular Vesicle Research at Creative Biolabs. “Our refined workflows are designed to improve consistency and reduce common co-isolated contaminants, helping researchers obtain well-characterized EV preparations for downstream analysis.”<\/p>\n

Every isolation project undergoes rigorous biophysical and biochemical characterization. Deliverables are verified utilizing Nanoparticle Tracking Analysis (NTA) for size distribution, Transmission Electron Microscopy (TEM) for morphological confirmation, and Western Blotting for canonical tetraspanin markers (e.g., CD9, CD63, CD81). These characterization steps provide researchers with documentation on particle size, morphology, and selected EV-associated markers prior to downstream use.<\/p>\n

Consult with the Scientific Team<\/strong><\/p>\n

Researchers can learn more about Creative Biolabs’ exosome isolation and characterization capabilities through the company’s extracellular vesicle research platform.<\/p>\n

Creative Biolabs strictly mandates that all exosome isolation, characterization, and development services are designated solely for Research Use Only (RUO).<\/p>\n

About Creative Biolabs<\/strong><\/p>\n

Creative Biolabs is a biotechnology service provider supporting extracellular vesicle research alongside broader drug discovery and preclinical research programs. Its exosome-related capabilities include custom isolation, characterization, multi-omics profiling, and cargo engineering.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Creative Biolabs
Contact Person:<\/strong> Candy Swift
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 1-631-830-6441
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.creative-biolabs.com\/exosome<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Creative Biolabs has expanded its custom exosome isolation platform to support extracellular vesicle research across complex biological matrices. New York, USA – August 26, 2026 – Designed exclusively for academic<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/610389"}],"collection":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/comments?post=610389"}],"version-history":[{"count":0,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/610389\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/media?parent=610389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/categories?post=610389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/tags?post=610389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}